Invesaro

Stocks BILL Financial statements

Financial statements

BILL Holdings, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 9 fiscal years, taken from the XBRL data BILL Holdings, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2018FY2020FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue64.91081582386421,0581,2901,4631,653
Cost of revenue19.429.939.161.8145194235272315
Gross profit45.578.41181764978641,0561,1901,338
Research and development1828.95389.5220315337340301
Selling and marketing19.330.145.167.9307516479544616
General and administrative1629.253.5128221249278282299
Operating expenses53.388.21532908141,1601,2301,2711,411
Operating income-7.82-9.8-34.2-114-317-296-174-80.6-73.4
Interest expense0.430.830.2328.29.4215.219.2
Interest income1.063.214.092.996.6991.3122
Other non-operating income0.632.333.16-25.4-13.972.914811163.3
Pre-tax income-7.19-7.47-31-139-331-223-26.330.4-10.1
Income tax0.01-0.160.05-40.6-4.320.812.566.611.11
Net income-7.2-7.31-31.1-98.7-326-224-28.923.8-11.2
EBITDA-5.5-6.65-33.1-109-305-280-151-53.1-17.5
EPS, basic-1.01-0.94-0.70-1.19-3.21-2.11-0.270.23-0.11
EPS, diluted-1.01-0.94-0.70-1.19-3.21-2.11-0.27-0.07-0.11
Shares, basic (weighted)7.167.844.182.810210610610499.9
Shares, diluted (weighted)7.167.844.182.810210610610499.9

Balance sheet

FY2018FY2020FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash and equivalents22.490.35745101,5971,6179861,0381,031
Short-term investments721246551,1081,0436021,180906
Receivables4.44.2518.22428.22832.331
Other current assets12.326.867.2151170297258302
Total current assets1,5132,3793,6066,2796,6736,3157,2397,435
Property, plant and equipment6.5613.948.95781.688117145
Lease right-of-use assets71.976.46959.456.147.8
Goodwill01,7722,3632,3972,3972,3972,397
Intangible assets417433361281223162
Other non-current assets6.6410.752.947.754.438.633.231.6
Total assets1,5262,4045,9699,2569,6369,17910,06410,218
Accounts payable5.063.4811.99.958.527.4516.39.64
Accrued liabilities6.5610.872120195300252387
Deferred revenue3.475.8912.831.926.31722.419.4
Total current liabilities1,3491,6772,3263,4093,7534,0634,5894,925
Lease liabilities86.682.772.562.858.448.5
Other non-current liabilities1.4513.83520.818.90.571.580.78
Total liabilities1,3531,6933,4405,2125,5505,0456,1506,688
Total debt9891,7731,8409141,7141,836
Paid-in capital14.78572,7774,5994,9475,2335,4155,626
Retained earnings-118-149-247-545-856-1,097-1,511-2,089
Other comprehensive income0.332.42-0.1-10.2-4.49-1.8910.2-6.42
Shareholders' equity-102-1037112,5304,0444,0864,1343,9143,531
Total equity-102-1037112,5304,0444,0864,1343,9143,531
Total liabilities and equity1,5262,4045,9699,2569,6369,17910,06410,218
Shares outstanding0.0194.510510710710392.1

Cash flow statement

FY2018FY2020FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Net income-7.2-7.31-31.1-98.7-326-224-28.923.8-11.2
Depreciation and amortization2.313.151.144.8711.515.523.227.555.9
Stock-based compensation1.554.0818.168.3197314248243230
Deferred income tax-0.180-40.6-4.07-1.36-0.36-0.080.28
Change in receivables-0.28-2.1-1.61-6.54-3.03-4.480.07-4.461.42
Change in payables-0.563.17-1.67.42-3.77-1.69-1.138.21-5.87
Cash from operations-8.36-3.95-4.434.62-18.1188279351416
Capital expenditures-1.31-2.74-11.4-18.9-5.38-7.59-0.98-4.34-3.33
Acquisitions0-556-144-28.900
Cash from investing-418-96.1-249-1,427-1,127259-409-817-28.6
Debt issued01,129560001,4000
Stock issued0.691.708.8612.817.916.511.611.9
Share buybacks00-87.6-212-430-560
Cash from financing3264928631,6402,879235-743667-173
Exchange rate effect00-0.15-0.04-0.24-0.29-0.05
Net change in cash-99.93926092171,733682-873199214
Free cash flow-9.67-6.69-15.9-14.3-23.5180278346412
Interest paid0.440.870.170.114.877.4412.613.819
Income taxes paid001.275.636.321.11

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $44.25 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin80.9%Gross profit / revenue.
Operating margin-4.4%Operating income / revenue.
EBITDA margin-1.1%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-0.6%Pre-tax income / revenue.
Net margin-0.7%Net income / revenue.
FCF margin25.0%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin25.2%Cash from operations / revenue.
Return on equity (ROE)-0.3%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-0.1%Net income / average total assets.
Return on invested capital (ROIC)-1.3%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue18.2%Research and development expense / revenue.
Stock-based pay / revenue13.9%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.2%Capital expenditures / revenue.
D&A / revenue3.4%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y13.0%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y16.0%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y47.3%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y12.4%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y15.7%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y50.0%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y-147.2%Net income vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y18.6%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y30.3%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y145.9%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y19.1%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y31.8%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y-9.8%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-4.8%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y6.9%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y1.5%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y2.0%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y11.4%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-3.8%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-1.9%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y3.8%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.51xCurrent assets / current liabilities.
Quick ratio0.40x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.39x(Cash + short-term investments) / current liabilities.
Debt / equity0.52xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets18.0%Total debt / total assets.
Liabilities / assets65.4%Total liabilities / total assets.
Net debt-$101.4MTotal debt - cash - short-term investments. Negative means more cash than debt.
Working capital$2.51BCurrent assets - current liabilities.
Goodwill and intangibles / assets25.0%(Goodwill + intangible assets) / total assets.
Tangible book value$971.9MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.16xRevenue / average total assets.
Fixed asset turnover12.6xRevenue / average property, plant and equipment.
Receivables turnover52.2xRevenue / average receivables.
Days sales outstanding7 days365 x average receivables / revenue.
Days payables15 days365 x average accounts payable / cost of revenue.
Capex / operating cash flow0.8%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted-$0.11Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic-$0.11Net income per basic share, as reported (split-adjusted).
Revenue per share$16.55Revenue / diluted weighted shares.
FCF per share$4.13Free cash flow / diluted weighted shares.
Operating cash flow per share$4.16Cash from operations / diluted weighted shares.
Book value per share$38.35Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$10.56Tangible book value / shares outstanding.
Cash per share$21.05(Cash + short-term investments) / shares outstanding.
Buybacks / FCF135.9%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$4.41BShare price x shares outstanding.
Enterprise value$4.31BMarket cap + total debt - cash - short-term investments.
P/S2.67xMarket cap / revenue.
P/B1.25xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book4.53xMarket cap / tangible book value, when positive.
P/FCF10.7xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF10.6xMarket cap / cash from operations, when positive.
EV/Sales2.60xEnterprise value / revenue.
EV/FCF10.4xEnterprise value / free cash flow, when both are positive.
FCF yield9.4%Free cash flow / market cap.
Earnings yield-0.3%Net income / market cap (the inverse of P/E).
Shareholder yield12.7%(Dividends paid + share buybacks) / market cap.
What was BILL Holdings, Inc.'s revenue in fiscal 2026?

BILL Holdings, Inc. reported revenue of $1.65B for fiscal 2026, 13% higher than the year before.

Was BILL Holdings, Inc. profitable in fiscal 2026?

No. It reported a net loss of $11.2M.

How much free cash flow did BILL Holdings, Inc. generate in fiscal 2026?

Cash from operations of $415.8M minus capital expenditures of $3.3M left free cash flow of $412.5M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to BILL Holdings, Inc.